Logo

Crossref


1. The Care of Preterm and Term Newborns with Respiratory Conditions: A Systematic Synthesis of Evidence from Low- and Middle-Income Countries

- Georgia Dominguez

- Oviya Muralidharan

- Rachel Lee Him

- Leila Harrison

- Tyler Vaivada

- Zulfiqar A. Bhutta

2. The Impact of Nonequilibrium Conditions in Lung Surfactant: Structure and Composition Gradients in Multilamellar Films

- Jenny Marie Andersson

- Kevin Roger

- Marcus Larsson

- Emma Sparr

3. Comparison of the Effectiveness of Beraksurf and Curosurf Exogenous Surfactants in the Treatment of Respiratory Distress Syndrome in Preterm Neonates: A Double-blind Randomized Study in the West of Iran

- Fatemeh Eghbalian

- Behnaz Basiri

- Behnaz Hatami

- Narges Mohammadi Parsa

- Ensiyeh Jenabi

4. Comparison of Efficacy of Beractant (SURVANTA®) and Poractant Alfa (CUROSURF®) in Preterm Infants With Respiratory Distress Syndrome in Tawam Hospital, Al Ain, UAE: A Retrospective Study

- Fahad Butt

- Huda Mohamad

- Nour Abusallout

- Alaa Zaineh

- Feryal El khatib

- Sarah Abdulrahman

- Sara Hamwi

- Mohamed Rahmani

- Mustafa Alabdullatif

5. In Vivo Evaluation of the Acute Pulmonary Response to Poractant Alfa and Bovactant Treatments in Lung-Lavaged Adult Rabbits and in Preterm Lambs with Respiratory Distress Syndrome

- Francesca Ricci

- Fabrizio Salomone

- Elke Kuypers

- Daan Ophelders

- Maria Nikiforou

- Monique Willems

- Tobias Krieger

- Xabier Murgia

- Matthias Hütten

- Boris W. Kramer

- Federico Bianco

6. Evaluation of the Potential Association Between Cannabinoid Receptor 2 Gene Q63R Polymorphism (Rs35761398) and Risk of RDS Development in Preterm Neonates

- Sima Binaafar

- Majid Kalani

- Fatemeh Nayeri

- Shiva Irani

- Vahid Salimi

- Mamak Shariat

- Nikoo Niknafs

- Hosein Dalili

- Elaheh Amini

- Tahereh Esmaeilnia Shirvani

- Amir-Kamal Hardani

- Roya Taheritafti

- Nasrin Ghasemi-Fakhr

- Mohsen Ghadami

- Javad Tavakkoly-Bazzaz

- Ali Rashidi-Nezhad

7. Expression of Concern for Comparison of the Efficacy of Three Natural Surfactants (Curosurf, Survanta, and Alveofact) in the Treatment of Respiratory Distress Syndrome Among Neonates: A Randomized Controlled Trial [Iran J Pediatr. 2016;26(5): e5743]

- Vahid Ziaee